Clinical Trials Browser

Phase 2 × Neoplasms, Plasma Cell × lestaurtinib × Clear all

NCT00242827 2012-08-23

Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma

Phase 2 Terminated

Neoplasms, Plasma Cell